GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)

GE HealthCare Technologies (GEHC) reported Net Income towards Common Stockholders of $411.0 million for Q1 2026, down 30.1% on a YoY basis from $588.0 million in Q1 2025, and down 31.73% quarter-over-quarter from $602.0 million in Q4 2025.

GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

GE HealthCare Technologies has reported Net Income towards Common Stockholders for 5 years, with the latest figure at $411.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 30.1% year-over-year to $411.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 10.42% YoY), and the FY2025 full-year result was $2.1 billion, up 4.57% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $411.0 million, down from $602.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $721.0 million in Q4 2024, with the low at $189.0 million in Q1 2023.
  • Historically, Net Income towards Common Stockholders has averaged $462.2 million across 5 years, with a median of $464.0 million in 2025.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders tumbled 51.41% — and 2024, when it soared 97.88%.
  • GE HealthCare Technologies' Net Income towards Common Stockholders stood at $554.0 million in 2022, then fell by 27.26% to $403.0 million in 2023, then jumped by 78.91% to $721.0 million in 2024, then decreased by 16.5% to $602.0 million in 2025, then slumped by 31.73% to $411.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $411.0 million (Q1 2026), $602.0 million (Q4 2025), and $464.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 238.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 411.00 Mn
Dec 31, 2025 602.00 Mn
Sep 30, 2025 464.00 Mn
Jun 30, 2025 500.00 Mn
Mar 31, 2025 588.00 Mn
Dec 31, 2024 721.00 Mn
Sep 30, 2024 470.00 Mn
Jun 30, 2024 428.00 Mn
Mar 31, 2024 374.00 Mn
Dec 31, 2023 403.00 Mn
Sep 30, 2023 375.00 Mn
Jun 30, 2023 418.00 Mn
Mar 31, 2023 189.00 Mn
Dec 31, 2022 554.00 Mn
Sep 30, 2022 487.00 Mn
Jun 30, 2022 485.00 Mn
Mar 31, 2022 389.00 Mn